ICICI Prudential US Bluechip Equity Fund - IDCW - Direct Plan

Other Plans and Options
  • 0.62 %Nav, as on 10-07-2025

  • Previous Nav

  • Net Change on 10-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Direct Plan - IDCW 51.60 58.08 14.49 16.81 15.36 16.32
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 4.00 19.22 11.48 17.17 14.54 8.05

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Direct Plan - IDCW Jan 03, 2013 14.49 16.81 15.36 1.17 3,112.72

Fund Holdings as on 30-June-2025

  • West Pharmaceutical Services Inc

  • Huntington Ingalls Industries Inc

  • Monolithic Power Systems Inc

  • Estee Lauder Cos Inc

  • Nike Inc

  • GE HealthCare Technologies Inc

  • Pfizer Inc

  • Allegion plc

  • US Bancorp Inc

  • Zimmer Biomet Holdings Inc

  • NXP Semiconductors NV

  • MarketAxess Holdings Inc

  • Boeing Co

  • Agilent Technologies Co Ltd

  • Walt Disney

  • Alphabet Inc

  • Constellation Brands Inc

  • Danaher Corp

  • Campbell Soup Co

  • Brown-Forman Corp

  • Adobe Inc

  • TRANSUNION

  • United Parcel Service Inc

  • International Flavors & Fragrances Inc

  • Bio-Rad Laboratories Inc

  • Salesforce.Com Inc

  • Oracle Corp

  • Applied Material (US)

  • Net Current Assets

  • Microchip Technology Inc.

  • Microsoft Corp

  • Veeva Systems Inc

  • Synopsys Inc

  • Corteva Inc

  • Mondelez International Inc

  • Charles Schwab Corp

  • Amazon com

  • Merck & Co Inc

  • Manhattan Associates Inc

  • Thermo Fisher Scientific Inc

  • Amgen Inc

  • Northrop Grumman Corp

  • Bristol-Myers Squibb Co

  • TERADYNE INC

  • IDEX Corp

  • Lam Research Corporation

  • The Clorox Company

  • Kenvue Inc

  • Autodesk

  • Masco Corp.

  • Cadence Design Systems Inc

  • Pepsico Inc

  • Biogen Inc

  • Comcast Corporation

  • Freeport-McMoRan Inc

  • Qualcomm Inc.

  • Workday Inc

  • Occidental Petroleum Corp

  • Epam Systems Inc

  • TREPS

  • Nordson Corporation .

  • ASML Holding NV-NY REG SHS

  • Yum China Holdings Inc.

  • Medtronic Plc

  • Alphabet Inc

  • Caterpillar Inc.

  • Hershey Co

View More

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 03-Jan-2013 and currently has an AUM of ₹3,112.72 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.45(0.62%)yesterday to ₹72.75.

Among its top 3 holdings the fund has exposure to West Pharmaceutical Services Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100